U.S. Big Pharma, Big Dividends

Pfizer

Market Cap: US$135.1b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Johnson & Johnson

Market Cap: US$432.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Merck

Market Cap: US$196.2b

Operates as a healthcare company worldwide.

Bristol-Myers Squibb

Market Cap: US$89.8b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Perrigo

Market Cap: US$3.0b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Zoetis

Market Cap: US$63.6b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Viatris

Market Cap: US$11.1b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Royalty Pharma

Market Cap: US$20.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Eli Lilly

Market Cap: US$650.4b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.